One-Year Outcomes Following Intravenous Ketamine Plus Digital Training Among Patients with Treatment-Resistant Depression: A Secondary Analysis of a Randomized Clinical Trial

This secondary analysis of a randomized clinical trial examines whether automated self-association training can prolong the antidepressant effect of a single infusion of ketamine beyond 1 month in patients with treatment-resistant depression.

Detalles Bibliográficos
Autores principales: Price, Rebecca B., Wallace, Meredith L., Mathew, Sanjay J., Howland, Robert H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2023
Materias:
Research Letter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10167566/
https://www.ncbi.nlm.nih.gov/pubmed/37155171
http://dx.doi.org/10.1001/jamanetworkopen.2023.12434
_version_ 1785038702971453440
author Price, Rebecca B.
Wallace, Meredith L.
Mathew, Sanjay J.
Howland, Robert H.
author_facet Price, Rebecca B.
Wallace, Meredith L.
Mathew, Sanjay J.
Howland, Robert H.
author_sort Price, Rebecca B.
collection PubMed
description This secondary analysis of a randomized clinical trial examines whether automated self-association training can prolong the antidepressant effect of a single infusion of ketamine beyond 1 month in patients with treatment-resistant depression.
format Online
Article
Text
id pubmed-10167566
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher American Medical Association
record_format MEDLINE/PubMed
spelling pubmed-101675662023-05-10 One-Year Outcomes Following Intravenous Ketamine Plus Digital Training Among Patients with Treatment-Resistant Depression: A Secondary Analysis of a Randomized Clinical Trial Price, Rebecca B. Wallace, Meredith L. Mathew, Sanjay J. Howland, Robert H. JAMA Netw Open Research Letter This secondary analysis of a randomized clinical trial examines whether automated self-association training can prolong the antidepressant effect of a single infusion of ketamine beyond 1 month in patients with treatment-resistant depression. American Medical Association 2023-05-08 /pmc/articles/PMC10167566/ /pubmed/37155171 http://dx.doi.org/10.1001/jamanetworkopen.2023.12434 Text en Copyright 2023 Price RB et al. JAMA Network Open. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the CC-BY License.
spellingShingle Research Letter
Price, Rebecca B.
Wallace, Meredith L.
Mathew, Sanjay J.
Howland, Robert H.
One-Year Outcomes Following Intravenous Ketamine Plus Digital Training Among Patients with Treatment-Resistant Depression: A Secondary Analysis of a Randomized Clinical Trial
title One-Year Outcomes Following Intravenous Ketamine Plus Digital Training Among Patients with Treatment-Resistant Depression: A Secondary Analysis of a Randomized Clinical Trial
title_full One-Year Outcomes Following Intravenous Ketamine Plus Digital Training Among Patients with Treatment-Resistant Depression: A Secondary Analysis of a Randomized Clinical Trial
title_fullStr One-Year Outcomes Following Intravenous Ketamine Plus Digital Training Among Patients with Treatment-Resistant Depression: A Secondary Analysis of a Randomized Clinical Trial
title_full_unstemmed One-Year Outcomes Following Intravenous Ketamine Plus Digital Training Among Patients with Treatment-Resistant Depression: A Secondary Analysis of a Randomized Clinical Trial
title_short One-Year Outcomes Following Intravenous Ketamine Plus Digital Training Among Patients with Treatment-Resistant Depression: A Secondary Analysis of a Randomized Clinical Trial
title_sort one-year outcomes following intravenous ketamine plus digital training among patients with treatment-resistant depression: a secondary analysis of a randomized clinical trial
topic Research Letter
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10167566/
https://www.ncbi.nlm.nih.gov/pubmed/37155171
http://dx.doi.org/10.1001/jamanetworkopen.2023.12434
work_keys_str_mv AT pricerebeccab oneyearoutcomesfollowingintravenousketamineplusdigitaltrainingamongpatientswithtreatmentresistantdepressionasecondaryanalysisofarandomizedclinicaltrial
AT wallacemeredithl oneyearoutcomesfollowingintravenousketamineplusdigitaltrainingamongpatientswithtreatmentresistantdepressionasecondaryanalysisofarandomizedclinicaltrial
AT mathewsanjayj oneyearoutcomesfollowingintravenousketamineplusdigitaltrainingamongpatientswithtreatmentresistantdepressionasecondaryanalysisofarandomizedclinicaltrial
AT howlandroberth oneyearoutcomesfollowingintravenousketamineplusdigitaltrainingamongpatientswithtreatmentresistantdepressionasecondaryanalysisofarandomizedclinicaltrial

Ejemplares similares